Deutsche Stiftung für Herzforschung
13
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Removal Of CytoKines With cytoSorbenTs After Inflammatory Response Reaction During Cardiac Surgery
Role: collaborator
Microvascular Cardiac Allograft Vasculopathy Trial
Role: collaborator
Vagal Nerve Stimulation for the Treatment of Persistent AF
Role: collaborator
Abnormal Coronary Vasomotion in Patients With Suspected Coronary Artery Disease (CAD)
Role: collaborator
Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation
Role: collaborator
Cognitive Training in Heart Failure Study (CogTrain-HF)
Role: collaborator
3-Month Home-based Training With Whole Body Vibration (WBV) Device in Patients With Heart Failure and Preserved Ejection Fraction (GALILEO-HFpEF-HOME) (GALILEOHOME)
Role: collaborator
Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock
Role: collaborator
The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG
Role: collaborator
Mi-RNAs and Specificity of Hs-TnT in Symptomatic ED Patients
Role: collaborator
Rehabilitation and Outcome for Patients on LVAD Support
Role: collaborator
Surgical Manipulation of the Aorta and Cerebral Infarction
Role: collaborator
Impact of Exercise Training on Exercise Capacity in Patients With Severe Chronic Heart Failure
Role: collaborator
All 13 trials loaded